Omada Health (OMDA)
NASDAQ • Healthcare
Last close at September 9, 2026 at 20:00 UTC
Metrics Over Time
Where the Money Goes
Q2 2026In plain terms: out of every $100 in revenue, Omada Health keeps $6 as net profit.
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings
Nov 5
in 56 daysQ4 2026% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS
Omada Health’s revenue topped expectations as it rose 43.1% to about $87.8 million in the second fiscal quarter of 2026, reported August 6, 2026, up from roughly $61.4 million a year ago. On the consensus comparison, revenue of $87.8 million topped the $80.0 million estimate (+9.7%). The quarter’s top line reflects demand for the company’s digital chronic-condition management and virtual support offerings, including cardiometabolic programs and weight management support for members using GLP-1 drugs. Profitability remained anchored by a high gross margin, with gross profit of roughly $63.8 million translating to gross margin of 72.6%. Cash generation was positive, with operating cash flow of about $4.0 million. For the next period, consensus calls for EPS of $0.09 on revenue of $85.5 million.
About Omada Health
Omada Health, listed on the NASDAQ Global Market as OMDA, provides digital healthcare services centered on chronic-condition management and virtual support in the United States. The company operates in healthcare information services and generated $260.2 million of revenue in FY2025.
Today's Snapshot
Yesterday OMDA fell 3.1% to 21.50.
Trading Volume
Above 10d avg 1.2M
1.6M
vs S&P 500 Today
Underperforming Market
-2.59%
Updated: September 10, 2026 at 12:24 UTC
Technical Indicators
All signalsHide signals
- EMA (5 indicators)$19.42 - $22.98Sell
- RSI (14)41.56Neutral
- Stochastic %K (14, 3, 3)13.15Buy
- MACD Level (12, 26)0.02Neutral
Peers & Related Assets
Get premium market insights delivered directly to your inbox.